BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 36175866)

  • 1. Nanoengineering facilitating the target mission: targeted extracellular vesicles delivery systems design.
    Song H; Chen X; Hao Y; Wang J; Xie Q; Wang X
    J Nanobiotechnology; 2022 Sep; 20(1):431. PubMed ID: 36175866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
    Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
    Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time.
    Kooijmans SAA; Fliervoet LAL; van der Meel R; Fens MHAM; Heijnen HFG; van Bergen En Henegouwen PMP; Vader P; Schiffelers RM
    J Control Release; 2016 Feb; 224():77-85. PubMed ID: 26773767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification.
    Liu Q; Li D; Pan X; Liang Y
    J Nanobiotechnology; 2023 Sep; 21(1):334. PubMed ID: 37717008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery.
    Pham TC; Jayasinghe MK; Pham TT; Yang Y; Wei L; Usman WM; Chen H; Pirisinu M; Gong J; Kim S; Peng B; Wang W; Chan C; Ma V; Nguyen NTH; Kappei D; Nguyen XH; Cho WC; Shi J; Le MTN
    J Extracell Vesicles; 2021 Feb; 10(4):e12057. PubMed ID: 33643546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles: powerful candidates in nano-drug delivery systems.
    Liu X; Cao Y; Wang S; Liu J; Hao H
    Drug Deliv Transl Res; 2024 Feb; 14(2):295-311. PubMed ID: 37581742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functionalized extracellular vesicles as advanced therapeutic nanodelivery systems.
    Lu M; Xing H; Xun Z; Yang T; Zhao X; Cai C; Wang D; Ding P
    Eur J Pharm Sci; 2018 Aug; 121():34-46. PubMed ID: 29733979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of engineered extracellular vesicles for targeted tumor therapy.
    Zhang F; Guo J; Zhang Z; Duan M; Wang G; Qian Y; Zhao H; Yang Z; Jiang X
    J Biomed Sci; 2022 Feb; 29(1):14. PubMed ID: 35189894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles as drug delivery systems: Why and how?
    Elsharkasy OM; Nordin JZ; Hagey DW; de Jong OG; Schiffelers RM; Andaloussi SE; Vader P
    Adv Drug Deliv Rev; 2020; 159():332-343. PubMed ID: 32305351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered Extracellular Vesicles as a Targeted Delivery Platform for Precision Therapy.
    Sun Y; Sun F; Xu W; Qian H
    Tissue Eng Regen Med; 2023 Apr; 20(2):157-175. PubMed ID: 36637750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface-engineered extracellular vesicles for targeted delivery of therapeutic RNAs and peptides for cancer therapy.
    Jayasinghe MK; Pirisinu M; Yang Y; Peng B; Pham TT; Lee CY; Tan M; Vu LT; Dang XT; Pham TC; Chen H; Leung AYH; Cho WC; Shi J; Le MT
    Theranostics; 2022; 12(7):3288-3315. PubMed ID: 35547755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Vesicle Nanoarchitectonics for Novel Drug Delivery Applications.
    Sharma S; Masud MK; Kaneti YV; Rewatkar P; Koradia A; Hossain MSA; Yamauchi Y; Popat A; Salomon C
    Small; 2021 Oct; 17(42):e2102220. PubMed ID: 34216426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Vesicles in the Treatment of Parkinson's Disease: A Review.
    Yang X; Ma Y; Xie H; Dong S; Rao G; Yang Z; Zhang J; Wu Q
    Curr Med Chem; 2021; 28(31):6375-6394. PubMed ID: 33441061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane vesicles nanotheranostic systems: sources, engineering methods, and challenges.
    Nie W; Wu G; Zhong H; Xie HY
    Biomed Mater; 2021 Feb; 16(2):022009. PubMed ID: 33307545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nature's carriers: leveraging extracellular vesicles for targeted drug delivery.
    Chen Q; Zheng Y; Jiang X; Wang Y; Chen Z; Wu D
    Drug Deliv; 2024 Dec; 31(1):2361165. PubMed ID: 38832506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the Multifaceted Roles of Extracellular Vesicles: Insights into Biology, Pharmacology, and Pharmaceutical Applications for Drug Delivery.
    Al-Jipouri A; Eritja À; Bozic M
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.